Clariant has agreed a strategic partnership to establish a 51-49% joint venture with India Glycols (IGL) in renewable ethylene oxide (EO) derivatives, subject to regulatory approvals. U.S. Bhartia has been designated chairman of the JV, which will employ about 200 people in India.
Clariant has committed to new 2030 targets to reduce CO2 emissions in line with the Science Based Targets initiative (SBTi), which has validated them. This follows the establishment last year a dedicated unit to accelerate its sustainability transformation. The targets are:
* 40% absolute reductions in Scope 1 (made directly during production) and 2 (emitted indirectly, mainly through consuming steam and electricity) greenhouse gas emissions (GHG) emissions on 2019 levels
* A 14% absolute reductions in Scope 3 (other indirect) GHG emissions on 2019 levels
Clariant’s Biofuels & Derivatives business line has formed a strategic partnership with Chemtex Global to market its Sunliquid technology for second-generation biofuel projects in China. It will supply technology licences, technical services and starter cultures from its proprietary enzyme and yeast platform, while Chemtex will offer engineering, procurement construction services.
Clariant has taken what exective chairman Hariold Kottmann (above) called “another significant step towards becoming a pure-play speciality chemical company”, by completing the sale of its Masterbatches business to PolyOne on 1 July. It expects to divest the Pigments business shortly, after which it will make with an extraordinary cash distribution of CHF 3.00/share to its shareholders.
Clariant is expanding its capabilities for the Hostapon SCI brand of isethionate derivatives at its site in Mount Holly, US, and Tarragona, Spain. This will comprise both capacity increases and modernisation via optimised energy consumption and aggregate options for new SI grades. It should come onstream during Q1 2021.
The news is entirely dominated by the coronavirus pandemic. Here, we summaries some of the key developments in the fine and speciality chemicals industry so far in April
Multiple companies are turning spare capacity over or building new capacity to supply hand sanitiser. Leading the way is Ineos, which had already built three such plants in the UK, France and Germany and has now announced plans to build a fourth at Etian, France, to serve hospitals in Paris, north-eastern France and Belgium.